StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
335
This month
4
This year
34
Publishing Date
2024 - 04 - 02
2
2024 - 03 - 13
2
2024 - 02 - 22
2
2024 - 02 - 14
3
2024 - 02 - 12
2
2024 - 02 - 10
2
2024 - 01 - 16
3
2023 - 12 - 13
4
2023 - 11 - 22
2
2023 - 07 - 21
2
2023 - 06 - 26
2
2023 - 06 - 02
2
2023 - 05 - 15
3
2023 - 05 - 08
2
2023 - 04 - 27
2
2023 - 04 - 20
3
2023 - 04 - 18
2
2023 - 02 - 22
2
2023 - 01 - 19
2
2023 - 01 - 18
2
2023 - 01 - 09
3
2023 - 01 - 06
2
2022 - 11 - 15
2
2022 - 11 - 07
2
2022 - 10 - 31
3
2022 - 10 - 17
2
2022 - 10 - 11
2
2022 - 10 - 10
2
2022 - 09 - 06
2
2022 - 09 - 05
4
2022 - 08 - 08
3
2022 - 08 - 04
2
2022 - 07 - 28
4
2022 - 06 - 20
3
2022 - 05 - 11
2
2022 - 04 - 26
3
2022 - 04 - 12
2
2021 - 10 - 04
2
2021 - 08 - 23
2
2021 - 08 - 19
4
2021 - 07 - 19
2
2021 - 07 - 12
2
2021 - 06 - 24
2
2021 - 06 - 21
3
2021 - 06 - 09
2
2021 - 05 - 21
3
2021 - 05 - 10
2
2021 - 04 - 23
2
2021 - 04 - 22
2
2021 - 04 - 14
2
2021 - 04 - 13
2
2021 - 04 - 07
1
2021 - 04 - 05
1
2021 - 03 - 29
1
2021 - 03 - 26
1
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 11
2
2021 - 03 - 08
1
2021 - 03 - 04
1
Sector
Commercial services
2
Communications
2
Consumer non-durables
3
Distribution services
1
Electronic technology
2
Finance
1
Health services
5
Health technology
335
Information
1
Manufacturing
22
N/a
6
Process industries
8
Producer manufacturing
2
Professional, scientific, and technical services
4
Retail trade
1
Technology services
1
Tags
Active
5
Advanced
4
Antibody
5
Approval
22
Biopharma
4
Biotech
12
Biotech-bay
4
Cancer
47
Cell
5
China
15
Chinese
15
Clinical-trials-phase-iii
4
Collaboration
6
Companies
19
Covid
8
Designation
5
Device
4
Diabetes
11
Disease
16
Drug
28
Dupixent
4
Expected
14
First
4
Global
57
Growing
9
Growth
50
Ibi351
6
Ibi362
9
Immunotherapy
7
Insulin
17
Iot
12
Liver
6
Lung
7
Market
139
Medical
5
Meeting
10
Merge
4
Money
4
N/a
296
News
4
Novartis
4
Obesity
9
Pharma
5
Phase 1
4
Positive
5
Reach
9
Report
53
Research
24
Results
14
Sanofi
8
Spac
5
Space
6
Study
37
Technology
9
Therapeutics
16
Therapy
17
Treatment
37
Trial
13
Trials
6
Tumors
7
Entities
Abbott laboratories
56
Abbvie inc.
111
Abcellera biologics inc
12
Ac immune sa
35
Adc therapeutics sa
13
Agios pharmaceuticals, inc.
10
Akouos, inc.
11
Alnylam pharmaceuticals, inc.
38
Amgen inc.
88
Astellas pharma inc
25
Astrazeneca plc
98
Aveo pharmaceuticals, inc.
25
Baxter international inc.
14
Becton, dickinson and company
21
Beigene, ltd.
19
Biocryst pharmaceuticals, inc.
13
Biogen inc.
20
Biontech se
14
Blueprint medicines corporation
20
Boston scientific corporation
10
Bristol-myers squibb company
106
Clovis oncology, inc.
20
Eli lilly and company
1710
Epizyme, inc.
20
Exelixis, inc.
13
Gilead sciences, inc.
35
Glaxosmithkline plc
107
Hutchison china meditech limited
11
Icon plc
10
Illumina, inc.
15
Incyte corporation
207
Insulet corporation
14
Johnson & johnson
175
Karyopharm therapeutics inc.
20
Ligand pharmaceuticals incorporated
10
Medtronic plc
14
Merus n.v.
21
Nektar therapeutics
10
Novartis ag
138
Novo nordisk a/s
83
Omeros corporation
15
Otonomy, inc.
13
Pfizer, inc.
80
Point biopharma global inc
10
Precision biosciences, inc.
11
Proqr therapeutics n.v.
18
Regeneron pharmaceuticals, inc.
36
Rigel pharmaceuticals, inc.
41
Sanofi
335
Takeda pharmaceutical company limited
42
Terumo corp
14
Teva pharmaceutical industries ltd
61
Thermo fisher scientific inc
14
Ucb s.a.
11
United therapeutics corporation
14
Verastem, inc.
11
Vertex pharmaceuticals incorporated
12
Veru inc.
57
Viatris inc.
18
Y-mabs therapeutics, inc.
18
Symbols
ABBV
211
ABT
253
ALNY
78
ALPMF
70
ALPMY
70
AMGN
170
AMRN
34
AZN
214
AZNCF
174
BAX
45
BDX
34
BHC
30
BIIB
53
BMRN
29
BMY
119
BNTX
167
BSX
25
BY
26
CMXHF
22
FNCTF
49
GILD
64
GLAXF
271
GLPG
39
GLPGF
39
GOOG
35
GOOGL
35
GSK
335
IGMS
37
INCY
121
IPHA
109
IPHYF
81
JNJ
576
KPTI
25
KYMR
29
LLY
335
MDT
45
MOBV
65
MOR
39
MPSYF
36
MRNA
34
NKTR
46
NVO
139
NVS
330
NVSEF
285
OCX
35
PFE
153
PRGO
112
PRVB
283
PTCT
35
RCFA
83
REGN
255
RLYB
34
SNY
4550
SNYNF
3608
TAK
60
TEVJF
224
TMO
43
TXMD
34
VTRS
87
VXRT
36
Exchanges
Amex
1
Nasdaq
335
Nyse
335
Crawled Date
2024 - 04 - 02
2
2024 - 03 - 13
2
2024 - 02 - 22
2
2024 - 02 - 14
3
2024 - 02 - 12
2
2024 - 02 - 10
2
2024 - 02 - 07
2
2024 - 01 - 16
3
2023 - 12 - 13
4
2023 - 11 - 22
2
2023 - 07 - 21
2
2023 - 06 - 26
2
2023 - 05 - 15
3
2023 - 05 - 08
2
2023 - 04 - 20
3
2023 - 04 - 18
2
2023 - 01 - 19
2
2023 - 01 - 18
2
2023 - 01 - 09
3
2023 - 01 - 06
2
2022 - 11 - 15
2
2022 - 11 - 07
2
2022 - 10 - 31
3
2022 - 10 - 17
2
2022 - 10 - 11
2
2022 - 10 - 10
2
2022 - 09 - 06
2
2022 - 09 - 05
4
2022 - 08 - 08
3
2022 - 08 - 04
2
2022 - 07 - 28
4
2022 - 06 - 20
3
2022 - 05 - 11
2
2022 - 04 - 26
3
2022 - 04 - 12
2
2021 - 10 - 04
2
2021 - 08 - 23
2
2021 - 08 - 19
4
2021 - 08 - 09
2
2021 - 07 - 27
2
2021 - 07 - 19
2
2021 - 06 - 24
2
2021 - 06 - 21
2
2021 - 06 - 09
2
2021 - 05 - 21
3
2021 - 05 - 10
2
2021 - 04 - 23
2
2021 - 04 - 22
2
2021 - 04 - 14
2
2021 - 04 - 13
3
2021 - 04 - 09
1
2021 - 04 - 07
1
2021 - 04 - 05
1
2021 - 03 - 29
1
2021 - 03 - 26
1
2021 - 03 - 25
1
2021 - 03 - 19
2
2021 - 03 - 11
2
2021 - 03 - 08
1
2021 - 03 - 04
1
Crawled Time
00:00
33
00:01
1
00:20
3
01:00
31
02:00
6
03:00
2
04:00
2
04:20
5
05:00
5
06:00
3
07:00
3
08:00
5
09:00
5
10:00
5
10:51
1
11:00
5
11:36
1
12:00
7
12:15
2
12:20
1
12:30
1
12:34
1
13:00
5
13:07
1
13:13
1
13:15
1
13:17
1
13:20
3
13:27
1
13:30
2
13:50
1
14:00
14
14:03
1
14:20
1
14:30
1
14:58
1
15:00
13
15:11
1
15:15
1
15:20
6
15:30
4
15:49
1
16:00
33
17:00
14
17:37
1
17:43
1
18:00
12
18:04
1
18:17
1
18:26
1
18:31
2
18:32
1
18:33
1
18:40
1
18:42
1
19:00
15
20:00
9
21:00
22
22:00
17
23:00
9
Source
www.biospace.com
39
www.fda.gov
32
www.globenewswire.com
13
www.preludetx.com
1
www.prnewswire.com
250
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Sanofi
symbols :
Lly
save search
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
Published:
2024-04-17
(Crawled : 20:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.0%
|
O:
0.0%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-0.16%
|
O:
-1.81%
H:
0.0%
C:
0.0%
biotech
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
Published:
2024-04-09
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
TMO
|
News
|
$574.59
4.78%
-1.12%
2.5M
|
Health Technology
|
-6.93%
|
O:
-2.01%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.42%
|
O:
-0.71%
H:
0.0%
C:
0.0%
BIO
|
$285.28
1.84%
0.0%
230K
|
Health Technology
|
-17.48%
|
O:
-2.71%
H:
0.52%
C:
0.24%
AVTR
|
$25.65
5.08%
0.0%
5.6M
|
Process Industries
|
-5.61%
|
O:
-1.7%
H:
1.08%
C:
0.55%
THMO
|
$0.718
10.46%
9.47%
5.5K
|
Health Technology
|
-21.81%
|
O:
4.99%
H:
2.78%
C:
-2.1%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.64%
|
O:
-0.32%
H:
0.0%
C:
0.0%
global
growth
market
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published:
2024-04-02
(Crawled : 05:00)
- prnewswire.com
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-5.85%
|
O:
-2.79%
H:
1.32%
C:
1.18%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-5.11%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
review
cancer
treatment
advanced
china
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Published:
2024-04-02
(Crawled : 05:00)
- globenewswire.com
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-5.85%
|
O:
-2.79%
H:
1.32%
C:
1.18%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-5.11%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
HCM
|
$18.2
7.44%
6.92%
120K
|
Health Technology
|
1.47%
|
O:
0.21%
H:
1.49%
C:
-0.06%
treatment
advanced
china
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
Published:
2024-03-27
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.26%
|
O:
-0.26%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-5.62%
|
O:
0.49%
H:
0.84%
C:
-0.07%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-5.95%
|
O:
1.06%
H:
0.0%
C:
0.0%
INCY
|
$51.62
-0.58%
-0.58%
2.5M
|
Health Technology
|
-8.19%
|
O:
-0.09%
H:
1.42%
C:
1.1%
ibi310
first
cancer
colon
therapy
study
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published:
2024-03-15
(Crawled : 14:30)
- prnewswire.com
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-6.83%
|
O:
0.21%
H:
0.97%
C:
0.7%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-3.42%
|
O:
0.05%
H:
0.14%
C:
-0.93%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.26%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.86%
|
O:
-0.7%
H:
0.73%
C:
-0.16%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-6.89%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.45%
|
O:
-0.02%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.84
0.74%
0.74%
340K
|
Health Technology
|
-6.14%
|
O:
-0.27%
H:
1.26%
C:
0.84%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
0.14%
|
O:
0.2%
H:
1.14%
C:
-1.18%
antibody
therapeutics
market
Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published:
2024-03-13
(Crawled : 18:00)
- prnewswire.com
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
-7.29%
|
O:
-0.64%
H:
0.94%
C:
-0.56%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.61%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.13%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-10.91%
|
O:
0.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.27%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
distribution
year
global
market
Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published:
2024-03-13
(Crawled : 01:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-3.27%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.01%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.61%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.13%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-7.46%
|
O:
0.59%
H:
0.01%
C:
-1.45%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.27%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
research
global
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published:
2024-03-11
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
4.01%
|
O:
2.01%
H:
0.0%
C:
-2.01%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.58%
|
O:
1.12%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-5.43%
|
O:
0.02%
H:
0.79%
C:
0.79%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-0.41%
|
O:
0.9%
H:
2.03%
C:
1.89%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-6.5%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-4.26%
|
O:
0.01%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
3.64%
|
O:
-0.19%
H:
0.22%
C:
-0.21%
global
set
growth
market
US Healthcare Advertising Market Analysis Report 2024-2032: A $23.5 Billion Industry in 2023 with Insights on Major Players' Sales and Advertising Spend
Published:
2024-03-09
(Crawled : 04:20)
- prnewswire.com
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
sales
report
market
Global Dilated Cardiomyopathy (DCM) Market Report 2024, with Company Profiles of the Top 10 Major Market Players
Published:
2024-03-07
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
7.33%
|
O:
3.21%
H:
0.0%
C:
-1.71%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.16%
|
O:
0.08%
H:
0.86%
C:
0.7%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.82%
|
O:
-0.68%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-6.26%
|
O:
-0.02%
H:
0.0%
C:
-2.29%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-10.85%
|
O:
0.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.79%
|
O:
-0.08%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
5.95%
|
O:
-0.03%
H:
0.62%
C:
0.5%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-0.35%
|
O:
-0.02%
H:
1.37%
C:
0.34%
company
report
global
market
Global Glucagon-Like Peptide 1 (GLP-1) Agonist Market Analysis Report 2024: A $133.5 Billion in 2030 Featuring Eli Lilly and Co, Pfizer, Sanofi, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk
Published:
2024-02-27
(Crawled : 01:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
6.72%
|
O:
-1.72%
H:
2.54%
C:
2.54%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-5.26%
|
O:
-2.2%
H:
2.39%
C:
1.34%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-5.19%
|
O:
-0.94%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
6.37%
|
O:
0.01%
H:
0.79%
C:
0.6%
report
agonist
global
market
United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published:
2024-02-22
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-7.54%
|
O:
0.37%
H:
0.58%
C:
0.58%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-7.81%
|
O:
0.89%
H:
0.4%
C:
0.17%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-4.98%
|
O:
0.57%
H:
0.47%
C:
-0.58%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-4.27%
|
O:
0.14%
H:
1.01%
C:
0.51%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-5.01%
|
O:
0.29%
H:
0.93%
C:
0.47%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-3.42%
|
O:
0.97%
H:
0.0%
C:
0.0%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-8.01%
|
O:
0.65%
H:
1.35%
C:
0.41%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-4.65%
|
O:
0.47%
H:
2.0%
C:
0.93%
pharmaceuticals
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-5.41%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
9.24%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-6.69%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$64.93
-4.38%
6.2K
|
Manufacturing
|
27.56%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-14.3%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-9.36%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-7.6%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-3.22%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.95%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-3.48%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-4.79%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-1.81%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
7.74%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-4.07%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Biosimilar Hormones Global Market Report 2024 - Niche Sectors Record Notable Market Contributions
Published:
2024-02-14
(Crawled : 03:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-14.36%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.39%
|
O:
-0.21%
H:
0.34%
C:
0.07%
biosimilar
report
global
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$541.144
-19.1%
24
|
Health Technology
|
8.23%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-3.33%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
12.33%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$55.69
0.02%
29K
|
Professional, Scientific, and T...
|
12.17%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
News
|
$574.59
4.78%
-1.12%
2.5M
|
Health Technology
|
1.82%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-6.83%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-5.44%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-1.93%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
1.97%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-3.77%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-4.89%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
News
|
$29.47
1.38%
1.36%
120K
|
Health Technology
|
-25.58%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-14.36%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
14.91%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.39%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published:
2024-02-14
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-3.33%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
12.33%
|
O:
0.87%
H:
0.21%
C:
-2.23%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-1.93%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
VRTX
|
$404.93
1.25%
1.43%
1.1M
|
Health Technology
|
-4.44%
|
O:
0.56%
H:
0.49%
C:
-0.12%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-14.36%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
14.91%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.39%
|
O:
-0.21%
H:
0.34%
C:
0.07%
disease
report
treatment
expansion
global
infections
market
Animal Therapeutics and Diagnostics Global Market Report 2024 - Dermatological Disease Management in Animals to Propel Market Growth
Published:
2024-02-13
(Crawled : 23:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
ZTS
|
$149.56
2.76%
0.0%
4.1M
|
Health Technology
|
-20.68%
|
O:
0.93%
H:
0.7%
C:
-0.6%
TMO
|
News
|
$574.59
4.78%
-1.12%
2.5M
|
Health Technology
|
1.82%
|
O:
0.56%
H:
1.3%
C:
1.22%
QGEN
|
$41.89
1.63%
0.0%
900K
|
Health Technology
|
-3.83%
|
O:
-1.14%
H:
1.3%
C:
1.2%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
ELAN
|
$13.46
4.1%
0.0%
4.6M
|
Process Industries
|
-17.59%
|
O:
1.53%
H:
1.16%
C:
0.82%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
QGEN
|
$41.89
1.63%
0.0%
900K
|
Health Technology
|
-3.83%
|
O:
-1.14%
H:
1.3%
C:
1.2%
PAHC
|
$13.63
4.44%
4.26%
110K
|
Health Technology
|
15.18%
|
O:
1.32%
H:
4.7%
C:
4.09%
NEOG
P
|
$12.3
4.41%
4.23%
2.6M
|
Health Technology
|
-28.35%
|
O:
-0.24%
H:
4.39%
C:
3.29%
management
propel
disease
report
animal
global
animals
dermatological
diagnostics
therapeutics
growth
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-1.11%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
14.97%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-11.92%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-6.64%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.73%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.78%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-1.17%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-0.8%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-1.23%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-2.99%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$15.13
0.93%
0.93%
470K
|
Health Technology
|
-17.68%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$404.93
1.25%
1.43%
1.1M
|
Health Technology
|
-5.01%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
0.16%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
-7.02%
2.7K
|
Health Technology
|
-6.2%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$51.62
-0.58%
-0.58%
2.5M
|
Health Technology
|
-10.24%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-20.69%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
14.2%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$375.13
1.73%
1.7%
340K
|
Health Technology
|
-6.1%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-7.65%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published:
2024-02-12
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
12.33%
|
O:
-0.57%
H:
0.04%
C:
-1.74%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-6.2%
|
O:
-1.46%
H:
1.04%
C:
0.97%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-1.19%
|
O:
0.09%
H:
0.0%
C:
-0.48%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-1.35%
|
O:
0.02%
H:
0.46%
C:
-0.14%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-4.06%
|
O:
-0.83%
H:
0.7%
C:
-0.27%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-4.61%
|
O:
-0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-0.7%
|
O:
-0.86%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
12.64%
|
O:
-1.77%
H:
0.46%
C:
0.41%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-6.6%
|
O:
-0.4%
H:
1.6%
C:
1.54%
report
health
treatment
care
global
market
← Previous
1
2
3
4
5
6
7
8
9
…
16
17
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
M
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.